drugset / Trial / NCT02046044

Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction

NCT02046044

Phase 4 Unknown 60 enrolled Kocaeli University
RandomizedParallel-groupOpen-labelTreatment

Summary

Study hypothesis: Comparing the effect of digoxin and ivabradine in chronic heart failure patients with a left ventricular ejection of 35% or lower and sinus rhythm with heart rate 70 beats per minute or higher, and who are taking maximal dose of a beta blocker if tolerated.

Timeline

Start
2014-01
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified 0.25 mg
Subject Ivabradine Small molecule 7.5 mg

Indications